Cargando…

A Case of Oropharyngeal Angioedema Following Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Mechanical Thrombectomy

A 72-year-old housewife presented with ischemic cerebrovascular stroke. Intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA) followed by mechanical thrombectomy under general anesthesia were attempted. The patient developed stridor and tongue swelling, in addition to hypot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shirazy, Mohamed, Chaari, Anis, Hakim, Karim, Bousselmi, Kamel, Kauts, Vipin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789049/ https://www.ncbi.nlm.nih.gov/pubmed/31605241 http://dx.doi.org/10.1007/s40800-019-0104-9

Ejemplares similares

Prevalence and Prognostic Impact of Hypernatremia in Sepsis and Septic Shock Patients in the Intensive Care Unit: A Single Centre Experience
por: Shirazy, Mohamed, et al.
Publicado: (2020)

Factors associated with increased pancreatic enzymes in septic patients: a prospective study
por: Chaari, Anis, et al.
Publicado: (2017)

Usefulness of ultrasound in the management of acute respiratory distress syndrome
por: Chaari, Anis, et al.
Publicado: (2019)

The Utility of Automated ASPECTS in Acute Ischemic Stroke for Intravenous Recombinant Tissue Plasminogen Activator (IV-rtPA) Therapy
por: Shibata, Soichiro, et al.
Publicado: (2022)

Intra-arterial administration of recombinant tissue-type plasminogen activator (rt-PA) causes more intracranial bleeding than does intravenous rt-PA in a transient rat middle cerebral artery occlusion model
por: Crumrine, R Christian, et al.
Publicado: (2011)

Successful systemic thrombolysis with rtPA in a patient with history of a life-threatening rtPA-associated orolingual angioedema
por: Pelz, Johann Otto, et al.
Publicado: (2017)

Intravenous rtPA versus mechanical thrombectomy in acute ischemic stroke: A historical cohort in Joinville, Brazil
por: Cabral, Norberto L., et al.
Publicado: (2016)

Current perspectives on the use of intravenous recombinant tissue plasminogen activator (tPA) for treatment of acute ischemic stroke
por: Chapman, Sherita N, et al.
Publicado: (2014)

A Retrospective Study of thrombolysis with 0.6 mg/kg Recombinant Tissue Plasminogen Activator (rt-PA) in Mild Stroke
por: Yang, Jie, et al.
Publicado: (2016)

Nebulized Recombinant Tissue Plasminogen Activator (rt-PA) for Acute COVID-19-Induced Respiratory Failure: An Exploratory Proof-of-Concept Trial
por: Chowdary, Pratima, et al.
Publicado: (2023)

Oropharyngeal angioedema induced by inhaled histamine.
por: Koh, Youngil I., et al.
Publicado: (2002)

Outcomes of Endovascular Mechanical Thrombectomy and Intravenous Tissue Plasminogen Activator for the Treatment of Vertebrobasilar Stroke
por: Brinjikji, Waleed, et al.
Publicado: (2014)

Screening for Plasminogen Mutations in Hereditary Angioedema Patients
por: Farkas, Henriette, et al.
Publicado: (2021)

Intravenous thrombolysis with rt-PA in stroke: experience of the moroccan stroke unit
por: Chtaou, Naima, et al.
Publicado: (2016)

Coronary aspiration thrombectomy after using intravenous recombinant tissue plasminogen activator in a patient with acute ischemic stroke: a case report
por: Mai Duy, Ton, et al.
Publicado: (2019)

Efficacy and Safety of Different Dosage of Recombinant Tissue-type Plasminogen Activator (rt-PA) in the Treatment of Acute Pulmonary Embolism: A Systematic Review and Meta-analysis
por: Amini, Shahideh, et al.
Publicado: (2021)

A Case of Propofol-Induced Oropharyngeal Angioedema and Bronchospasm
por: You, Byung-Chul, et al.
Publicado: (2012)

Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator
por: Khalid, Muhammad, et al.
Publicado: (2018)

Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency
por: Rathbun, Kimberly M
Publicado: (2019)

The Role of the Plasminogen Activation System in Angioedema: Novel Insights on the Pathogenesis
por: Napolitano, Filomena, et al.
Publicado: (2021)

Comparative study of intravenous thrombolysis with rt-PA and urokinase for patients with acute cerebral infarction
por: Sun, Fan, et al.
Publicado: (2020)

Factors predicting the outcome of intravenous thrombolysis in stroke patients before rt-PA administration
por: Mehrpour, Masoud, et al.
Publicado: (2019)

Veno-occlusive disease (VOD) of the liver in Korean patients following allogeneic bone marrow transplantation (BMT): efficacy of recombinant human tissue plasminogen activator (rt-PA) treatment.
por: Lee, J. H., et al.
Publicado: (1996)

Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction
por: Zhou, Xiangchen, et al.
Publicado: (2022)

Mutant plasminogen in hereditary angioedema is bypassing FXII/kallikrein to generate bradykinin
por: Hintze, Stefan, et al.
Publicado: (2023)

uPA-mediated plasminogen activation is enhanced by polyphosphate
por: Whyte, Claire S., et al.
Publicado: (2020)

Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Zhu, Jianzhong, et al.
Publicado: (2022)

Efficacy and safety of rt-PA intravenous thrombolysis in patients with wake-up stroke: A meta-analysis
por: Liu, Hongfa, et al.
Publicado: (2022)

Retracted: Clinical Effect of Butylphthalide Combined with Rt-PA Intravenous Thrombolysis in the Treatment of Acute Cerebral Infarction
por: and Biomechanics, Applied Bionics
Publicado: (2023)

Intravenous Tissue Plasminogen Activator in Combination With Mechanical Thrombectomy: Clot Migration, Intracranial Bleeding, and the Impact of “Drip and Ship” on Effectiveness and Outcomes
por: Chang, Adam, et al.
Publicado: (2020)

Evaluation of Cerebral Perfusion in Patients Undergoing Intravenous Recombinant Tissue Plasminogen Activator Thrombolysis
por: HIRANO, Teruyuki
Publicado: (2015)

Substitution of citrate with tissue plasminogen activator (rt-PA) for catheter lock does not improve patency of tunnelled haemodialysis catheters in a randomised trial
por: Richtrova, Pavlina, et al.
Publicado: (2021)

Serum Creatinine May Indicate Risk of Symptomatic Intracranial Hemorrhage After Intravenous Tissue Plasminogen Activator (IV tPA)
por: Marsh, Elisabeth B., et al.
Publicado: (2013)

Intravenous r-tPA Dose Influence on Outcome after Middle Cerebral Artery Ischemic Stroke Treatment by Mechanical Thrombectomy
por: Kurminas, Marius, et al.
Publicado: (2020)

Meta-analysis of Vascular Imaging Features to Predict Outcome Following Intravenous rtPA for Acute Ischemic Stroke
por: Nogueira, Ricardo C., et al.
Publicado: (2016)

Retracted: Efficacy of Rosuvastatin Combined with rt-PA Intravenous Thrombolytic Therapy for Elderly Acute Ischemic Stroke Patients
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Mechanical thrombectomy combined with recombinant tissue plasminogen activator thrombolysis in the venous sinus for the treatment of severe cerebral venous sinus thrombosis
por: ZHEN, YONG, et al.
Publicado: (2015)

Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
por: Chaucer, Benjamin, et al.
Publicado: (2018)

Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
por: Madden, Bryan, et al.
Publicado: (2015)

Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers
por: Aparicio, Hugo J., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_riqv0is3rkdol2jg4pi6a0i7au